The global plasma fractionation market value was USD 29.83 Billion in 2025, driven by the growing demand for plasma-derived therapies across the globe. The market size is anticipated to grow at a CAGR of 6.70% during the forecast period of 2026-2035 to achieve a value of USD 57.06 Billion by 2035.
Base Year
Historical Period
Forecast Period
Compound Annual Growth Rate
6.7%
Value in USD Billion
2026-2035
*this image is indicative*
Plasma fractionation is the process of breaking down and separating the different components of blood plasma collected from donors. The proteins separated from the plasma are used as a therapeutic product for prevention and treatment of life-threatening diseases such as immunological disorders, blood clotting disorders, and others.
The EMR’s report titled “Plasma Fractionation Market Report and Forecast 2026-2035 offers a detailed analysis of the market based on the following segments:
Market Breakup by Product
Market Breakup by Method
Market Breakup by Application
Market Breakup by End User
Market Breakup by Region
Immunoglobulins hold a significant share in the market for plasma fractionation because of their ability to treat autoimmune diseases and increase immune response. Coagulation factor concentrates help in the formation of blood clots whereas albumin is involved in the movement of molecules through blood. HIV progression is slowed down with the help of protease inhibitors. All these products largely contribute to the growth of the market.\
Improved infrastructure and facilities in hospitals have made it the largest shareholder in the market for plasma fractionation. Hospitals and clinics are now providing treatment facilities for various autoimmune diseases using plasma products which is why it is predicted to dominate the market in the forecast period as well. Clinical research laboratories are also researching for new and innovative therapy techniques, contributing to the growth of the plasma fractionation market.
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the global plasma fractionation market, covering their competitive landscape and latest developments like mergers, acquisitions, investments, and expansion plans.
CSL Plasma LLC was founded in 1916 and has its headquarter in Florida, United States. Its parent company CSL Behring makes use of human plasma to treat bleeding disorders, neurological disorders, immune deficiency, inherited respiratory disease, and hereditary angioedema.
Grifols S.A. was founded in 1940. Based out of Barcelona, Spain, it is a Spanish company specialising in the manufacture of pharmaceuticals and chemicals. It mainly produces blood plasma-based products among other instruments, and reagents to be used in clinical testing.
Biotest Group is known globally for developing and supplying biotherapeutic drugs and plasma protein products. It was established in 1946 and has its headquarter in Dreieich, Germany.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other market players include Takeda Pharmaceutical Company Limited, and Baxter International Inc., among others.
Upto 15% Off
USD
$3299 $2969
$5499 $4949
$6999 $5949
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The plasma fractionation market was valued at USD 29.83 Billion in 2025.
The market is expected to grow at a CAGR of 6.70% from 2026 to 2035 to reach a value of USD 57.06 Billion by 2035.
The major market drivers are increasing geriatric population and increasing use of immunoglobulins.
Major trends in the market are prevalence of respiratory diseases and bleeding disorders and increase in the number of plasma collection centres worldwide.
The regional markets can be divided into North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa.
Key players in the global plasma fractionation market are CSL Plasma LLC, Grifols, S.A., Takeda Pharmaceutical Company Limited, Biotest Group, and Baxter International Inc., among others.
Plasma fractionation is the process of breaking down and separating the different components of blood plasma collected from donors.
The market is segmented based on product, application, processing technology, end use, and region.
Proteins separated from plasma are used as a therapeutic product for prevention and treatment of life-threatening diseases such as immunological disorders, blood clotting disorders, and others.
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment
|
| Breakup by Product |
|
| Breakup by Method |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share